CLDI•benzinga•
Calidi Biotherapeutics And City Of Hope Provide Update On Phase 1 Clinical Trial With CLD-101 Virotherapy In Patients With Recurrent High-Grade Glioma; Says 'To date, 14 participants have been treated and all treatment has been well tolerated. The study i
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on March 26, 2025 by benzinga